1. Data & Insights

Beyond Throughput: Building Reverification Strategies That Safeguard Access

Today’s guest post comes from Gregory Morris, Chief Strategy Officer at CareMetx.

Gregory examines how Annual Reverification (AR) processes must evolve in response to changing payer dynamics and increasing benefit complexity. Rather than focusing solely on throughput and operational efficiency, he argues for the importance of more nuanced strategies that help ensure patients maintain access to therapy—even when coverage details shift behind the scenes.

To learn about CareMetx’s solution, download the case study: Rethinking Annual Reverification: A Strategic, Multi-Layered Approach to Protecting Patient Access.

Read on for Gregory’s insights.

Read more »

       
View Original Article
https://www.drugchannels.net/
Do you like Drug Channels's articles? Follow on social!